Kruschitz Renate, Wallner-Liebmann Sandra, Lothaller Harald, Luger Maria, Ludvik Bernhard
Medical University Vienna, Clinic for Internal Medicine III, Department of Endocrinology & Metabolism, Vienna, Austria.
Obes Facts. 2017;10(2):76-84. doi: 10.1159/000454836. Epub 2017 Apr 5.
Structured obesity treatment programs at primary care level are becoming increasingly important. However, evidence from current treatment approaches in the long term is lacking. In view of this fact we evaluated a standardized, meal replacement-based weight loss program (myLINE®; AENGUS, Graz, Austria) according to the currently applicable guidelines.
Data of overweight and obese individuals (n = 70) who participated at least 36 months in the program were analyzed. Data were collected at baseline (T0) as well as after 1, 3, 6, 12, 24, and 36 (T1-T36) months. Body composition was measured by conventional anthropometry and bioelectrical impedance analysis.
Compared to T0, a maximum weight, BMI, fat mass, absolute body cell mass (BCM) reduction and an increase of relative BCM could be seen at T6. Subsequently, the findings reveal a significant reduction of body weight and body fat and a satisfying development of body cell mass during the observation period of 36 months.
The evaluated program complies with national and international guidelines for the therapy of obesity in adults and is efficient and meaningful for a long-term therapeutic use in primary care..
基层医疗层面的结构化肥胖治疗项目正变得愈发重要。然而,目前治疗方法的长期证据尚缺。鉴于此,我们依据当前适用指南对一项标准化的、基于代餐的减肥项目(myLINE®;奥地利格拉茨的AENGUS公司)进行了评估。
对至少参与该项目36个月的超重和肥胖个体(n = 70)的数据进行分析。在基线期(T0)以及1、3、6、12、24和36个月(T1 - T36)后收集数据。通过传统人体测量学和生物电阻抗分析来测量身体成分。
与T0相比,在T6时可观察到体重、体重指数、脂肪量、绝对身体细胞质量(BCM)最大程度降低以及相对BCM增加。随后,研究结果显示在36个月的观察期内体重和体脂显著降低,身体细胞质量呈现令人满意的变化。
所评估的项目符合成人肥胖治疗的国家和国际指南,对于基层医疗中的长期治疗应用而言既有效又有意义。